written on 12.05.2014

Overcoming Clinical Challenges in Brazil


In 2012, Brazil ranked sixth in pharmaceutical spending. By 2017, IMS predicts that the country will rise to fourth, just behind Japan. Ideally, performing clinical trials in Brazil averages a cost savings of 20 to 30 percent as compared to Western markets. Though Brazil boasts a national healthcare program, the Unified Health System (SUS), it […]